PL2170104T3 - Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienie - Google Patents
Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienieInfo
- Publication number
- PL2170104T3 PL2170104T3 PL08766831T PL08766831T PL2170104T3 PL 2170104 T3 PL2170104 T3 PL 2170104T3 PL 08766831 T PL08766831 T PL 08766831T PL 08766831 T PL08766831 T PL 08766831T PL 2170104 T3 PL2170104 T3 PL 2170104T3
- Authority
- PL
- Poland
- Prior art keywords
- food composition
- dementia patients
- prodromal dementia
- csf
- tau
- Prior art date
Links
- 206010012289 Dementia Diseases 0.000 title abstract 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 abstract 3
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 abstract 2
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 abstract 1
- 229940045145 uridine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
- A23P20/10—Coating with edible coatings, e.g. with oils or fats
- A23P20/15—Apparatus or processes for coating with liquid or semi-liquid products
- A23P20/18—Apparatus or processes for coating with liquid or semi-liquid products by spray-coating, fluidised-bed coating or coating by casting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Confectionery (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/NL2007/050310 WO2009002148A1 (en) | 2007-06-27 | 2007-06-27 | Food composition for prodromal dementia patients |
| EP08766831.5A EP2170104B2 (en) | 2007-06-27 | 2008-06-20 | Food composition for prodromal dementia patients |
| PCT/NL2008/050408 WO2009002164A1 (en) | 2007-06-27 | 2008-06-20 | Food composition for prodromal dementia patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2170104T3 true PL2170104T3 (pl) | 2012-02-29 |
Family
ID=39085446
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08766831T PL2170104T3 (pl) | 2007-06-27 | 2008-06-20 | Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienie |
| PL11181091T PL2412250T3 (pl) | 2007-06-27 | 2008-06-20 | Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienie |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11181091T PL2412250T3 (pl) | 2007-06-27 | 2008-06-20 | Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienie |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8445458B2 (pl) |
| EP (2) | EP2170104B2 (pl) |
| JP (1) | JP5906014B2 (pl) |
| CN (1) | CN101686723A (pl) |
| AT (1) | ATE524077T1 (pl) |
| AU (1) | AU2008269726B2 (pl) |
| BR (1) | BRPI0813912B1 (pl) |
| CA (1) | CA2704906C (pl) |
| DK (1) | DK2412250T3 (pl) |
| ES (2) | ES2551237T3 (pl) |
| FI (1) | FI2170104T4 (pl) |
| HU (1) | HUE028126T2 (pl) |
| IL (1) | IL202967A (pl) |
| MX (1) | MX2009014217A (pl) |
| NZ (1) | NZ582265A (pl) |
| PL (2) | PL2170104T3 (pl) |
| PT (2) | PT2170104E (pl) |
| RU (1) | RU2487557C2 (pl) |
| WO (2) | WO2009002148A1 (pl) |
| ZA (1) | ZA200909227B (pl) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110104214A1 (en) | 2004-04-15 | 2011-05-05 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
| WO2009002146A1 (en) | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Supporting activities of daily living |
| WO2009002148A1 (en) | 2007-06-27 | 2008-12-31 | N.V. Nutricia | Food composition for prodromal dementia patients |
| US20100331258A1 (en) * | 2007-06-26 | 2010-12-30 | N.V. Nutricia | memory in subjects with mini-mental state examination of 24-26 |
| WO2009082203A1 (en) | 2007-12-20 | 2009-07-02 | N.V. Nutricia | Liquid nucleotides/nucleosides-containing product |
| WO2009002145A1 (en) | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Lipid composition for improving function of brain functioning |
| EP3654535A1 (en) * | 2008-02-01 | 2020-05-20 | Guangdong Oppo Mobile Telecommunications Corp., Ltd. | System and method for uplink timing synchronization in conjunction with discontinuous reception |
| IT1392312B1 (it) * | 2008-12-16 | 2012-02-24 | Pharmarte S R L | Formulazione per la somministrazione vaginale a base di acidi grassi polinsaturi omega-3 e di composti del magnesio. |
| WO2013066152A1 (en) * | 2011-10-31 | 2013-05-10 | N.V. Nutricia | Method for improving executive function |
| WO2013066153A1 (en) | 2011-10-31 | 2013-05-10 | N.V. Nutricia | Composition for improving neuropsychological test battery score |
| WO2013066151A1 (en) | 2011-10-31 | 2013-05-10 | N.V. Nutricia | Improving recognition |
| WO2013066168A1 (en) * | 2011-10-31 | 2013-05-10 | N.V. Nutricia | Composition for improving neuropsychological test battery score |
| WO2013129931A1 (en) | 2012-03-02 | 2013-09-06 | N.V. Nutricia | Method for improving functional synaptic connectivity |
| WO2013129914A1 (en) | 2012-03-02 | 2013-09-06 | N.V. Nutricia | Method for improving functional synaptic connectivity |
| WO2013154733A1 (en) * | 2012-04-09 | 2013-10-17 | Hill James W | Protein restriction for disease prevention and treatment |
| US20160136192A1 (en) * | 2013-06-10 | 2016-05-19 | Abbott Laboratories | Methods and compositions for enhancing cognitive performance |
| WO2015115886A1 (en) * | 2014-01-31 | 2015-08-06 | N.V. Nutricia | Method for treating, stabilizing or slowing down brain glucose metabolism deficit |
| WO2015115885A1 (en) | 2014-01-31 | 2015-08-06 | N.V. Nutricia | Method for reducing white matter lesions, white matter hyperintensities (wmh), leukoaraiosis or periventricular white matter disease in elderly |
| GB201405033D0 (en) | 2014-03-20 | 2014-05-07 | Isis Innovation | Combination therapy |
| US10166252B2 (en) * | 2014-04-14 | 2019-01-01 | N.V. Nutricia | Method for assessing and treating or preventing impaired plasma polar lipid levels |
| WO2017069613A1 (en) | 2015-10-23 | 2017-04-27 | N.V. Nutricia | Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients |
| WO2017155386A1 (en) * | 2016-03-08 | 2017-09-14 | N.V. Nutricia | Method for treating brain atrophy |
| WO2017155387A1 (en) | 2016-03-08 | 2017-09-14 | N.V. Nutricia | Method for supporting memory function and/or cognitive function |
| WO2017213490A1 (en) | 2016-06-10 | 2017-12-14 | N.V. Nutricia | Method for controlling neuroinflammation |
| WO2018038599A1 (en) | 2016-08-23 | 2018-03-01 | N.V. Nutricia | Product and method for increasing uridine concentration in blood plasma |
| JP7523905B2 (ja) * | 2016-09-29 | 2024-07-29 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 認知症でない患者における神経保護薬としての、ω３脂肪酸、一酸化窒素放出化合物及びビタミンＢ１２ |
| CA3054846A1 (en) * | 2017-04-11 | 2018-10-18 | Societe Des Produits Nestle S.A. | Omega-3 fatty acid and vitamin d levels to identify and attenuate cognitive aging in individuals |
| JP6818331B2 (ja) * | 2019-04-24 | 2021-01-20 | 株式会社Ｈｂｃフナト | 軽度認知障害を治療又は予防するための組成物 |
| CN117956908A (zh) * | 2021-09-17 | 2024-04-30 | N·V·努特里奇亚 | 适合作为营养组合物或补充剂用于患有脑相关障碍、衰退或疾病的动物的固体组合物 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3600197A (en) * | 1968-08-27 | 1971-08-17 | Merck & Co Inc | Flavor enhancing compositions for foods and beverages |
| AU4595985A (en) | 1984-08-10 | 1986-02-13 | Sentrachem Limited | Cancer treatment |
| JP2525624B2 (ja) | 1987-09-21 | 1996-08-21 | 雪印乳業株式会社 | 多価不飽和脂肪酸配合育児用粉乳 |
| JPH06237734A (ja) | 1991-11-06 | 1994-08-30 | Sanwa Kagaku Kenkyusho Co Ltd | 機能後退性疾患用食品組成物 |
| JP3576318B2 (ja) | 1996-06-19 | 2004-10-13 | 明治乳業株式会社 | 核酸関連物質含有栄養組成物 |
| JPH10136937A (ja) | 1996-11-08 | 1998-05-26 | Takashi Morita | 脳細胞機能向上、血管細胞強化、身体各細胞機能向上栄養総合食品 |
| ATE221324T1 (de) * | 1996-11-20 | 2002-08-15 | Nutricia Nv | Fette enthaltende ernährungszusammensetzung zur behandlung des stoffwechselssyndroms |
| JP3731983B2 (ja) * | 1997-08-27 | 2006-01-05 | 明治製菓株式会社 | 痴呆犬の夜鳴き改善薬 |
| US20070004670A1 (en) * | 1998-07-31 | 2007-01-04 | Richard Wurtman | Compositions containing citicoline, and methods of use thereof |
| US8518882B2 (en) * | 1998-07-31 | 2013-08-27 | Massachusetts Institute Of Technology | Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same |
| FR2787799B1 (fr) | 1998-12-23 | 2001-03-09 | Rhodia Chimie Sa | Composition comprenant une ecorce inorganique et un noyau comportant au moins un compose polyhydroxyle |
| GB9916536D0 (en) * | 1999-07-14 | 1999-09-15 | Scarista Limited | Nutritional or pharmaceutical compositions |
| EP1090636A1 (en) | 1999-09-13 | 2001-04-11 | Société des Produits Nestlé S.A. | High lipid diet |
| GB9925709D0 (en) | 1999-10-30 | 1999-12-29 | Smithkline Beecham Plc | Composition |
| US6835750B1 (en) * | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
| US7226916B1 (en) | 2000-05-08 | 2007-06-05 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
| SK287423B6 (sk) | 2001-04-30 | 2010-09-07 | Trommsdorff Gmbh & Co. Kg Arzneimittel | Farmaceuticky účinné uridínové estery, ich použitie, spôsob ich prípravy a farmaceutický prostriedok |
| US6942874B2 (en) | 2001-05-25 | 2005-09-13 | Linguagen Corp. | Nucleotide compounds that block the bitter taste of oral compositions |
| EP1285590A1 (en) | 2001-08-08 | 2003-02-26 | Société des Produits Nestlé S.A. | Lipid blends |
| NL1019368C2 (nl) * | 2001-11-14 | 2003-05-20 | Nutricia Nv | Preparaat voor het verbeteren van receptorwerking. |
| US20030114415A1 (en) † | 2001-12-14 | 2003-06-19 | Wurtman Richard J. | Compositions and methods for treating and preventing memory impairment using citicoline |
| US20040001817A1 (en) * | 2002-05-14 | 2004-01-01 | Giampapa Vincent C. | Anti-aging nutritional supplement |
| JP4943853B2 (ja) | 2003-10-24 | 2012-05-30 | エヌ．ブイ．・ヌートリシア | 免疫調節性オリゴ糖 |
| US7090879B2 (en) | 2004-03-18 | 2006-08-15 | Abbott Laboratories | Nutritional formula containing select carotenoid combinations |
| BRPI0510857A (pt) * | 2004-05-13 | 2007-12-26 | Massachusetts Inst Technology | efeitos da uridina na liberação de dopamina |
| CN102600199A (zh) * | 2004-09-15 | 2012-07-25 | 麻省理工学院 | 含有尿苷的组合物及使用其的方法 |
| EP1656839A1 (en) | 2004-11-11 | 2006-05-17 | N.V. Nutricia | Nutrition containing lipid blend |
| US20060252775A1 (en) | 2005-05-03 | 2006-11-09 | Henderson Samuel T | Methods for reducing levels of disease associated proteins |
| PL1888081T3 (pl) * | 2005-05-23 | 2017-07-31 | Massachusetts Institute Of Technology | Kompozycje zawierające PUFA i sposoby ich zastosowania |
| EP1915144A4 (en) | 2005-06-20 | 2009-08-19 | Accera Inc | METHOD FOR REDUCING OXIDATIVE DAMAGE AND IMPROVING MITOCHONDRIA EFFICIENCY |
| JP5967855B2 (ja) | 2005-06-30 | 2016-08-10 | サントリーホールディングス株式会社 | 日中活動量の低下および／又はうつ症状の改善作用を有する組成物 |
| JP5697293B2 (ja) | 2005-06-30 | 2015-04-08 | サントリーホールディングス株式会社 | 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物 |
| CN103211807A (zh) * | 2005-07-08 | 2013-07-24 | Dsmip资产公司 | 用于治疗痴呆和前痴呆相关病症的多不饱和脂肪酸 |
| WO2007058523A1 (en) * | 2005-11-17 | 2007-05-24 | N.V. Nutricia | Composition with docosapentaenoic acid |
| US20070140992A1 (en) * | 2005-12-21 | 2007-06-21 | Lynn Schick | Taste masking of essential oils using a hydrocolloid |
| ATE509624T1 (de) * | 2005-12-23 | 2011-06-15 | Nutricia Nv | Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz |
| WO2009002145A1 (en) | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Lipid composition for improving function of brain functioning |
| WO2009002148A1 (en) | 2007-06-27 | 2008-12-31 | N.V. Nutricia | Food composition for prodromal dementia patients |
| US20100331258A1 (en) * | 2007-06-26 | 2010-12-30 | N.V. Nutricia | memory in subjects with mini-mental state examination of 24-26 |
| WO2009082203A1 (en) * | 2007-12-20 | 2009-07-02 | N.V. Nutricia | Liquid nucleotides/nucleosides-containing product |
| WO2009002146A1 (en) | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Supporting activities of daily living |
-
2007
- 2007-06-27 WO PCT/NL2007/050310 patent/WO2009002148A1/en active Application Filing
-
2008
- 2008-06-20 EP EP08766831.5A patent/EP2170104B2/en active Active
- 2008-06-20 US US12/666,617 patent/US8445458B2/en active Active
- 2008-06-20 PT PT08766831T patent/PT2170104E/pt unknown
- 2008-06-20 AT AT08766831T patent/ATE524077T1/de active
- 2008-06-20 CA CA2704906A patent/CA2704906C/en active Active
- 2008-06-20 BR BRPI0813912A patent/BRPI0813912B1/pt active IP Right Grant
- 2008-06-20 NZ NZ582265A patent/NZ582265A/en unknown
- 2008-06-20 RU RU2010102526/13A patent/RU2487557C2/ru active
- 2008-06-20 PT PT111810917T patent/PT2412250E/pt unknown
- 2008-06-20 ES ES11181091.7T patent/ES2551237T3/es active Active
- 2008-06-20 CN CN200880022198A patent/CN101686723A/zh active Pending
- 2008-06-20 MX MX2009014217A patent/MX2009014217A/es active IP Right Grant
- 2008-06-20 WO PCT/NL2008/050408 patent/WO2009002164A1/en active Application Filing
- 2008-06-20 DK DK11181091.7T patent/DK2412250T3/en active
- 2008-06-20 HU HUE11181091A patent/HUE028126T2/en unknown
- 2008-06-20 PL PL08766831T patent/PL2170104T3/pl unknown
- 2008-06-20 PL PL11181091T patent/PL2412250T3/pl unknown
- 2008-06-20 JP JP2010514660A patent/JP5906014B2/ja active Active
- 2008-06-20 ES ES08766831T patent/ES2373001T3/es active Active
- 2008-06-20 FI FIEP08766831.5T patent/FI2170104T4/fi active
- 2008-06-20 EP EP11181091.7A patent/EP2412250B1/en not_active Revoked
- 2008-06-20 AU AU2008269726A patent/AU2008269726B2/en active Active
-
2009
- 2009-12-23 ZA ZA200909227A patent/ZA200909227B/xx unknown
- 2009-12-24 IL IL202967A patent/IL202967A/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200909227B (en) | Food composition for prodromal dementia patients | |
| PL2162019T3 (pl) | Kompozycja lipidowa do poprawy czynności mózgu | |
| WO2006017627A3 (en) | Dietary compositions comprising docosahexaenoic acid and eicosapentaenoic acid and use thereof for treating insulin resistance | |
| MXPA06000318A (es) | Pano limpiador y metodos para mejorar la salud de la piel. | |
| MY146109A (en) | Oligosaccharide mixture | |
| MY162076A (en) | Use of vitamin e tocotrienols for the inhibition of intracellularly obligate pathogen chlamydia | |
| GB0514463D0 (en) | Use of pinolenic acid | |
| HRP20130531T1 (en) | Method for producing a concentrate of eicosapentaenoic and docosahexaenoic acid esters | |
| TW200740379A (en) | Nutrition for obese patients | |
| WO2009050580A8 (fr) | Composition destinee a la regulation du metabolism des lipides | |
| EP2241196A3 (en) | Nutritional supplement comprising oligosaccharides and cysteine for treating hiv | |
| UA88030C2 (ru) | Композиция, которая содержит омега-3-жирные кислоты и омега-6-жирные кислоты, для лечения синдрома сухого глаза | |
| WO2008094825A3 (en) | Compositions and methods for maintaining, strengthening, improving or promoting eye health | |
| NZ599292A (en) | Vitamin d compositions and method of administration to a human being | |
| EP3318251A3 (en) | Composition for preventing or treating obesity or lipid-related metabolic disease | |
| HK1135022A1 (en) | Methioninase inhibitor and composition and food or drink containing the same | |
| PL1799027T3 (pl) | Rośliny o nasionach niezawierających nasyconych kwasów tłuszczowych lub o zmniejszonej zawartości kwasów tłuszczowych i olej pozyskany z takich nasion | |
| EP1980258A4 (en) | COMPOSITION FOR IMPACTING BLOOD PRESSURE AND / OR PREVENTING BLOOD PRESSURE INCAPATION AND FOOD OR BEVERAGE CONTAINING THEREOF | |
| WO2006109194A3 (en) | Chromium-fatty acid compounds and methods of making and using thereof | |
| EP1508335A4 (en) | COMPOSITIONS AGAINST PERIODONTAL BACTERIA AND COMPOSITION-CONTAINING FOODS, BEVERAGES AND MUD RINSING AGAINST PERIODONTAL BACTERIA | |
| EP2801356A3 (en) | DHA and EPA for the reduction of oxidative stress | |
| ATE258435T1 (de) | Pinolensäure gegen diabetes | |
| WO2007135518A3 (en) | Use of choline-based preparations for the treatment of tinnitus | |
| PT2055199E (pt) | Composição de tempero | |
| Hundal | Indian Medical Students' Knowledge and Attitudes about HIV/AIDS |